First Long Island Investors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$27.4M Sell
112,213
-1,743
-2% -$406K 2.23% 17
2025
Q4
$23.6M Buy
113,956
+275
+0.2% +$54.4K 1.73% 20
2025
Q3
$21.1M Sell
113,681
-926
-0.8% -$159K 1.57% 24
2025
Q2
$17.5M Sell
114,607
-2,333
-2% -$359K 1.37% 30
2025
Q1
$19.4M Sell
116,940
-2,734
-2% -$428K 1.6% 27
2024
Q4
$17.3M Sell
119,674
-80
-0.1% -$12.4K 1.38% 29
2024
Q3
$19.4M Sell
119,754
-1,019
-0.8% -$162K 1.53% 27
2024
Q2
$17.7M Sell
120,773
-62,670
-34% -$9.32M 1.49% 28
2024
Q1
$29M Sell
183,443
-2,416
-1% -$385K 2.42% 14
2023
Q4
$29.1M Sell
185,859
-2,807
-1% -$430K 2.59% 15
2023
Q3
$29.4M Buy
188,666
+491
+0.3% +$81K 2.85% 10
2023
Q2
$31.1M Sell
188,175
-18,283
-9% -$2.95M 2.99% 9
2023
Q1
$32M Sell
206,458
-27,524
-12% -$4.44M 3.25% 8
2022
Q4
$41.3M Sell
233,982
-981
-0.4% -$169K 4.34% 4
2022
Q3
$38.4M Sell
234,963
-1,636
-0.7% -$277K 4.26% 4
2022
Q2
$42M Sell
236,599
-10,670
-4% -$1.9M 4.37% 4
2022
Q1
$43.8M Sell
247,269
-8,227
-3% -$1.4M 3.73% 6
2021
Q4
$43.7M Buy
255,496
+1,650
+0.7% +$270K 3.43% 6
2021
Q3
$41M Buy
253,846
+6,982
+3% +$1.19M 3.51% 9
2021
Q2
$40.7M Sell
246,864
-7,302
-3% -$1.21M 3.48% 8
2021
Q1
$41.8M Sell
254,166
-2,502
-1% -$405K 3.71% 7
2020
Q4
$40.4M Buy
256,668
+26,351
+11% +$3.89M 3.77% 8
2020
Q3
$34.3M Buy
230,317
+77,445
+51% +$11.5M 3.54% 8
2020
Q2
$21.5M Buy
152,872
+857
+0.6% +$125K 2.44% 16
2020
Q1
$19.9M Buy
152,015
+31,491
+26% +$4.47M 2.71% 14
2019
Q4
$17.6M Buy
120,524
+10,591
+10% +$1.44M 1.97% 20
2019
Q3
$14.2M Buy
109,933
+1,466
+1% +$193K 1.74% 25
2019
Q2
$15.1M Buy
108,467
+922
+0.9% +$128K 1.88% 23
2019
Q1
$15M Buy
107,545
+2,890
+3% +$387K 1.94% 22
2018
Q4
$13.5M Buy
104,655
+15
+0% +$2.09K 2.01% 22
2018
Q3
$14.5M Buy
104,640
+2,518
+2% +$335K 1.87% 21
2018
Q2
$12.4M Buy
102,122
+2,114
+2% +$264K 1.77% 26
2018
Q1
$12.8M Buy
100,008
+1,105
+1% +$149K 1.77% 27
2017
Q4
$13.8M Buy
98,903
+244
+0.2% +$34K 1.88% 24
2017
Q3
$12.8M Buy
98,659
+2,604
+3% +$345K 1.86% 24
2017
Q2
$12.7M Buy
96,055
+3,364
+4% +$429K 1.97% 21
2017
Q1
$11.5M Sell
92,691
-373
-0.4% -$44.6K 1.92% 23
2016
Q4
$10.7M Buy
93,064
+3,142
+3% +$363K 1.87% 26
2016
Q3
$10.6M Sell
89,922
-498
-0.6% -$60.4K 1.92% 19
2016
Q2
$11M Buy
90,420
+2,193
+2% +$249K 2.03% 16
2016
Q1
$9.55M Sell
88,227
-6,677
-7% -$691K 1.82% 27
2015
Q4
$9.75M Buy
94,904
+2,889
+3% +$291K 1.85% 23
2015
Q3
$8.59M Sell
92,015
-1,715
-2% -$166K 1.78% 28
2015
Q2
$9.13M Buy
93,730
+2,460
+3% +$246K 1.77% 29
2015
Q1
$9.18M Buy
91,270
+6,285
+7% +$639K 1.8% 28
2014
Q4
$8.89M Buy
84,985
+800
+1% +$84.3K 1.76% 29
2014
Q3
$8.97M Buy
84,185
+3,140
+4% +$326K 1.96% 20
2014
Q2
$8.48M Buy
81,045
+2,465
+3% +$249K 1.99% 17
2014
Q1
$7.72M Buy
78,580
+1,130
+1% +$105K 1.91% 20
2013
Q4
$7.09M Buy
77,450
+2,175
+3% +$200K 1.79% 25
2013
Q3
$6.53M Buy
75,275
+2,860
+4% +$257K 1.83% 26
2013
Q2
$6.22M Buy
+72,415
New +$6.15M 1.96% 19

Other funds holding JNJ

First Long Island Investors's JNJ Position: Q1 2026 in Review

First Long Island Investors reduced its Johnson & Johnson (JNJ) stake by 1.5% in Q1 2026, selling an estimated $406K and leaving 112,213 shares worth $27.4M. The position accounts for 2.23% of the portfolio, ranked #17.

First Long Island Investors first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $43.8M in Q1 2022. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • First Long Island Investors held 112,213 shares of Johnson & Johnson worth $27.4M as of Q1 2026.
  • First Long Island Investors sold 1,743 Johnson & Johnson shares in Q1 2026, an estimated $406K.
  • Johnson & Johnson made up 2.23% of First Long Island Investors's portfolio in Q1 2026, its #17 holding.
  • First Long Island Investors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • First Long Island Investors's Johnson & Johnson position peaked at $43.8M in Q1 2022.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on First Long Island Investors's 13F filing for Q1 2026, filed 15 May 2026.